ZVRA Zevra Therapeutics

• None no insider bought on the open market
• $138K sold by 1 insider outside a trading plan
• $2.4M sold by 5 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Neil F. McFarlane CEO
   Planned sale
   $225K 20,000 shares at $11.25 4.6% of stake
   Traded Oct 12 Filed Oct 13
   ↗
3. Rahsaan Thompson Chief Legal & Compliance
   Planned sale
   $475K 42,666 shares at $11.13 53% of stake
   Traded Aug 14 Filed Aug 17
   ↗
4. Corey Michael Watton Director
   Sale
   $138K 12,300 shares at $11.25 87% of stake
   Traded Aug 10 Filed Aug 12
   ↗
5. Rahsaan Thompson Chief Legal & Compliance
   Planned sale
   $438K 34,557 shares at $12.68 30% of stake
   Traded Jun 22 Filed Jun 23
   ↗
6. Rahsaan Thompson Chief Legal & Compliance
   Planned sale
   $20K 1,794 shares at $11.30 3.6% of stake
   Traded May 11 Filed May 13
   ↗
7. Neil F. McFarlane CEO
   Planned sale
   $125K 14,625 shares at $8.56 3.6% of stake
   Traded Feb 9 Filed Feb 10
   ↗
8. Joshua Schafer CCO
   Planned sale
   $97K 10,500 shares at $9.19 14% of stake
   Traded Feb 3 Filed Feb 4
   ↗
9. Timothy J. Sangiovanni SVP, Finance & Corp Controller
   Planned sale
   $28K 3,000 shares at $9.18 9.2% of stake
   Traded Feb 3 Filed Feb 4
   ↗
10. Joshua Schafer CCO
    Planned sale
    $30K 3,375 shares at $8.83 8.3% of stake
    Traded Jan 30 Filed Feb 2
    ↗
11. Adrian W Quartel Chief Medical Officer
    Planned sale
    $40K 4,533 shares at $8.83 32% of stake
    Traded Jan 30 Filed Feb 2
    ↗
12. Rahsaan Thompson Chief Legal & Compliance
    Planned sale
    $36K 4,080 shares at $8.83 7.6% of stake
    Traded Jan 30 Filed Feb 2
    ↗
13. Timothy J. Sangiovanni SVP, Finance & Corp Controller
    Planned sale
    $15K 1,750 shares at $8.82 7.7% of stake
    Traded Jan 30 Filed Feb 2
    ↗
14. Neil F. McFarlane CEO
    Planned sale
    $853K 91,000 shares at $9.38 20% of stake
    Traded Feb 2 Filed Feb 2
    ↗
15. Neil F. McFarlane CEO
    Planned sale
    $211K 19,500 shares at $10.82 8.1% of stake
    Traded Oct 10, 2025 Filed Oct 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 option exercises and 1 share withholding for taxes.